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Abstract
Background: Synaptosomal-associated protein 25 (SNAP-25) may be contribute to the pathogenesis of fibromyalgia Syndrome (FMS) by affecting the release 
of neurotransmitters. Objectives: We aimed to investigate the relationship between the SNAP-25 gen (DdeI = rs1051312 and MnlI = rs3746544) polymorphism 
and the temperament and character traits. Methods: A total of 85 female patients diagnosed with FMS and 70 age-matched healthy female subjects were enrolled 
into the study. The Temperament and Character Inventory (TCI) were performed on all the patients. SNAP-25 gene polymorphism was determined in the 
patients group and controls group. Results: No significant difference between groups was found regarding the distribution of SNAP-25 MnlI polymorphism 
(p > 0.05), but it was seen that the frequency of TC genotype for DdeI gene was higher in the patients group (p < 0.05). Increased hazard avoidance was 
found in the patients group (p < 0.05). When TCI scores were assessed in terms of SNAP-25 gene polymorphism, no statistically significant relationship was 
detected between the TT, TG, GG genotypes for MnlI gen and TCI scores (p > 0.05). However, increased hazard avoidance was detected in patients with TC 
genotype for DdeI gene compared to patients without such genotype. Discussion: SNAP-25 might be an etiological factor in FMS pathogenesis and might 
affect personality traits of FMS patients by mediating neurotransmitter release. 
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Introduction
Fibromyalgia syndrome (FMS) is a common chronic musculoskeletal 
disorder characterized with widespread pain and multiple sensitive 
points in physical examinations, the etiology of which is not 
completely known. It is a syndrome accompanied by many systemic 
disorders. Although it is an illness which can be seen in every age 
group, its frequency increases with age. It is most common between 
the ages 20 and 55. It is mostly seen in women1. 
Co-diagnosis of psychiatric disorders in FMS is common. When 
previous studies are considered, the most common psychiatric 
disorders that coexist with FMS are depression, somatization 
disorder, bipolar disorder, anxiety and obsessive compulsive 
disorder2,3. Assuming that some personality and temperament traits 
may predispose to FMS, character evaluation studies have been 
conducted, and various disorders have been found in personality 
inventory profiles4. Although symptoms that involve many 
systems can be seen, the symptom that bothers patients most is 
widespread pain. Unfortunately, there is no effective treatment of 
FMS. This is an important problem not only for patients, but also 
for clinicians. Therefore, studies for etiopathogenesis usually target 
the enlightenment of pathogenesis of pain. While the etiology 
and mechanisms of FMS are still not thoroughly understood, 
however, pain mechanisms and central sensitization in addition 
to neuroendocrine dysfunctions seem to be the most important 
factors in occurrence of FMS. Many factors can trigger or modulate 
neuroendocrine anomalies in FMS. Because psychiatric disorders 
frequently accompany to FMS, studies performed to enlighten 
its etiopathogenesis usually focus on psychiatric disorders and 
pain mechanisms5. As known, serotonin and dopamine are the 
neurotransmitters, the roles of which have been widely discussed 
in the etiology of depression and anxiety disorders. Recent studies 
have found that levels of serotonin, noradrenalin and dopamine are 
distinctly low in FMS patients6. 
SNARE (soluble N-ethylmaleimide-sensitive factor activating 
protein receptor) proteins are proteins that have basic role in fusion 
between eukaryotic cells and organelles, and between organelles and 
plasma membrane7. Synaptosomal-associated protein 25 (SNAP-25) 
is a SNARE protein found in plasma membrane. These proteins 
play a very important role in regulation of voltage-gated calcium 
channels and transmission of neurotransmitters between nerve 
cells. Neurotransmitters are found in synaptic vesicles, and are sent 
to the other synapse by way of exocytose8. It is essential for normal 
brain functions. Several studies have reported that abnormalities in 
structure and expression of SNAP-25 are associated with various 
neurological disorders9,10. For this reason, SNAP-25 may be 
contributing to the pathogenesis of FMS by mediating the release of 
neurotransmitters such as serotonin and dopamine. In a study carried 
out by Balkarli et al.11 which was the preliminary of our study, it was 
reported that SNAP-25 gene polymorphism was more frequently 
detected in FMS. Depression and pain score was higher in patients 
with DdeI T/C genotype. Therefore, we intend to investigate the 
relationship between SNAP-25 gen (DdeI = rs1051312 and MnlI = 
rs3746544) polymorphism and the temperament and character traits. 
Methods
Patients and evaluation 
A total of 85 female patients diagnosed with FMS according to the 
ACR 2010 FMS diagnostic criteria, and 70 age-matched healthy 
female subjects were enrolled in the study. Postmenopausal or 
climacteric female patients were not enrolled in the study. Here, the 
objective was to reduce the effect of hormonal changes, and to reduce 
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the effect of osteoporosis which usually accompanies to FMS in the 
postmenopausal period. Because depression affects personality and 
temperament traits, all the patients were evaluated with the Beck 
depression inventory (BDI) during the screening phase. The patients, 
whose BDI scores were ≥11, were excluded from the study. We tried 
to minimize the contribution of depression to personality traits. In 
order to obtain accurate data about the symptoms of the patients, 
subjects graduated at least from 8th class or attending 8th class were 
enrolled to the study, since more educated patients explain their 
symptoms better. All patients and healthy subjects were informed 
on the study. After informed consents from the patients group and 
controls were obtained, their blood samples were collected into 
10 cc EDTA tubes, and were kept at –20oC. Genetic analyses were 
performed on the samples in the Medical Genetics Department. 
The Temperament and Character Inventory (TCI) consisting of 240 
questions was performed and assessed on both groups. Approval of 
the local ethics committee was obtained for the study.
Tools 
Socio-demographic Information Form
This form was developed by the investigators, and data such as age, 
gender, educational background, socioeconomic status, place of 
residence, marital status and duration of illness were recorded on 
the form.
BDI
This inventory was used to determine the depression risk of subjects, 
and to measure the changes in level and severity of depressive 
symptoms. It was developed by Beck et al., and the studies for 
validation, reliability testing and adaptation of it into Turkish were 
conducted by Hisli12.
TCI
It is a self-report inventory that evaluates four temperament and three 
character traits, which is filled out as “wrong/correct”, which consists 
of 240 items, which can be completed in 30-45 minutes, and which 
can be applied to people 17 and above years old. All dimensions 
except for the persistence were divided into three and five subscales. 
In the temperament dimension, novelty seeking (NS) was divided 
into 4 subscales (NS1: exploratory excitability, NS2: impulsiveness, 
NS3: extravagance, NS4: disorderliness); and harm avoidance (HA) 
was divided into 4 subscales (HA1: anticipatory worry, HA2: fear of 
uncertainty, HA3: shyness, HA4: fatigability); and reward dependence 
(RD) was divided into 3 subscales (RD1: sentimentality, RD3: 
attachment, RD4: dependence). In the character dimension, self-
directedness (SD) was divided into 5 subscales (SD1: responsibility, 
SD2: purposefulness, SD3: resourcefulness, SD4: self-acceptance, SD5: 
enlightened second nature); and cooperativeness (C) was divided into 
5 subscales (C1: social acceptance, C2: empathy, C3: helpfulness, C4: 
compassion, C5: pure-hearted conscience); and self-transcendence 
(ST) was divided into 3 subscales (ST1: self-forgetfulness, ST2: 
transpersonal identification, ST3: spiritual acceptance)13.
Molecular analysis
Genetic analyses were performed at the Medical Genetics 
Department. Genomic DNAs of the patients and the controls were 
isolated from peripheral blood by using QuickGene DNA whole 
blood kit (Kurabo, Japan). In order to multiply the UTR region of 
the 8th exon, where the DdeI (rs1051312) and MnlI (rs3746544) 
polymorphisms of the SNAP-25 gene are found, the primary 
sequences predefined in the literature as forward 5’- TTC TCC TCC 
AAA TGC TGT CG-3’ and reverse 5’- CCA CCG AGG AGA GAA 
AAT G-3’ were used.
In the PCR reaction, which was formed by using these primary 
sequences, 10X PCR Buffer, 5 μl dNTP mixture containing 0,2 mM 
of every nucleotide, and Taq polymerase enzyme were also used. 
The PCR reaction conditions performed: After the first 2-minute 
denaturation at 95°C, following 35 cycles consisting of 1 minute at 
58°C and 2 minutes at 72°C, a final extension of 7 minutes at 72°C.
10 U DdeI and 10 U MnlI enzymes were separately added to 
the PCR products of 261 base pairs obtained, and they were left to 
fragmentation at 37°C for 14 hours. For separation of the fragments 
that were formed after fragmentation, 3.5% ultra-pure agarose 
gel was prepared. Then, the PCR products were subjected to gel 
electrophoresis for 40-50 minutes, and divided into fragments. The 
allele band sequencings expected for DdeI polymorphism after 
electrophoresis for the T allele: an uncut band of 261 base pairs; for 
the C allele: two separate bands of 228 base pairs and 33 base pairs. 
The allele band sequencings expected for MnlI polymorphism for 
the T allele: two separate bands of 256 base pairs and 5 pairs, for 
the G allele: three separate bands of 210 base pairs, 46 base pairs 
and 5 base pairs.
Statistical analysis 
Statistical package for the Social Sciences (SPSS) (IBM Corp, 
Armonk, New York, USA) 20.0 software was used for statistical 
evaluation. Descriptive statistics included mean, standard deviation 
and percentage. The confidence interval of the study was determined 
as 95%. First of all, Kolmogorov-Smirnov normality test was 
conducted for analysis of the differences between the ages, number of 
births, and number of children of the patients group and the controls 
group. At the end of the normality test, it was decided to use Mann-
Whitney U test for the nonparametric tests. For analysis of marital 
status of the patients group and control group, Fischer’s exact test was 
used. For analysis of the differences between the patients group and 
the controls group in terms of the places they live in, occupational 
status, and MnlI, DdeI genes; Pearson chi-square test was used. Allele 
frequencies were calculated with the Hardy-Weinberg equation. p, q: 
allele frequency, p2, q2, 2pq: genotype frequency. p+q=1
(p2)+(2pq)+(q2)=1
Spearman correlation analysis was used to identify associations 
between the parameters. p < 0.05 was considered statistically 
significant.
Results
Of the patients, the mean age was 41.2 ± 5.3 years, and the mean 
durations of the symptoms was 7.43 ± 1.9 years, and the mean level 
of hemoglobin was 12.97 ± 0.81 g/dL. Eighty one (95.2%) patients 
were married, and 4 (4.8%) patients were single. Sixty two (72.9%) 
patients lived in the city, and 23 (23%) patients lived in the country. 
Twenty eight (32.9%) patients were working, and 57 (67.1%) patients 
were unemployed. The patients group and the controls group were 
similar with regards to their ages, marital status, the places they live 
in and occupational status. 
When the MnlI (rs3746544) gene polymorphism distribution 
in the patients group and the controls group were reviewed, there 
were 38 subjects (44.70%) with TT genotype, 39 subjects (45.88%) 
with TG genotype, and 8 subjects (9.41%) with GG genotype. In the 
control group, there were 32 subjects (45.71%) with TT genotype, 23 
subjects (32.86%) with TG genotype, and 15 subjects (21.42%) with 
GG genotype. When the DdeI (rs1051312) genotype distribution 
was reviewed, there were 35 subjects (41.1%) with TT genotype, 47 
subjects (55.2%) with TC genotype, and 3 subjects (3.5%) with CC 
genotype in the patients group. In the control group, there were 46 
subjects (65.7%) with TT genotype, 19 subjects (27.1%) with TC 
genotype, and 5 subjects (7.1%) with CC genotype. No difference 
between the groups was found regarding the distribution of SNAP-25 
MnlI polymorphism, but statistically significant difference was found 
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between the groups with regards to DdeI polymorphism (p = 0.004). 
When a separate matchings review was done to find out the source of 
the difference, it was seen that the difference was caused by the higher 
number of TC genotype in the patients group. No difference was found 
between the two groups with regards to allele frequency (Table 1).
When the TCI scores of the patients group and controls were 
compared, NS, NS4 and RD4 scores of the patients were found lower 
than those of the control group (p values 0.002, < 0.001, < 0.001 
respectively), and HA, HA1, HA2, HA4, S5 scores were found higher 
in the patients compared to controls (p < 0.05), (Table 2). 
Table 1. SNAP-25 gene allele and genotype distribution in the patients group and controls group
Patients n, % Controls n, % p
Mnl1 gene genotype/allele  
TT 38 (44.70%) 32 (45.71%) 0.248
TG 39 (45.88%) 23 (32.86%)
GG 8 (9.41%) 15 (21.42%)
T allele 115 (67.6%) 87 (62.14%) 0.500 (Pearson chi-square)
Odds ratio 1.193 (95% CI 0.714-1.995)G allele 55 (32.4%) 53 (38.85%)
HWE p = 0.718 HWE p = 0.037
DdeI gene
TT 35 (41.1%) 46 (65.7%) 0.004
TC 47 (55.2%) 19 (27.1%)
CC 3 (3.5%) 5 (7.1%)
T allele 117 (68.82%) 111 (79.28%) 0.089 (Pearson chi-square)
Odds ratio 1.62 (95% CI 0.926-2.849C allele 53 (31.17%) 29 (20.71%)
HWE p = 0.004 HWE p = 0.330
SNAP 25: Synaptosomal-associated protein 25, HWE: Hardy-Weinberg equation.
Table 2. TCI values of Patients Group and Control Group
TCI parameter Patients n = 85 Controls n = 70 P
NS 15.73 ± 4.78 18,16 ± 4,780 0.002
NS1 5.38 ± 2.17 5,67 ± 1,835 0.299
NS2 4.88 ± 7.06 4,05 ± 2.125 0.998
NS3 3.46 ± 1.586 3.46 ± 1.908 0.115
NS4 2.64 ± 1.445 4.47 ± 1.872 < 0.001
HA 20.48 ± 6.81 16.63 ± 5.811 < 0.001
HA1 6.62 ± 1.769 5.58 ± 2.095 0.003
HA2 4.25 ± 1.796 3.37 ± 1.665 0.003
HA3 3.98 ± 2.569 3.98 ± 2.569 0.441
HA4 5.46 ± 2.181 3.89 ± 2.177 < 0.001
RD 13.14 ± 2.954 14.23 ± 3.123 0.71
RD1 7.32 ± 1.53 7.16 ± 1.73 0.546
RD3 3.76 ± 1.549 4.19 ± 1.586 0.065
RD4 1.94 ± 1.165 2.88 ± 1.196 < 0.001
P 5.29 ± 1.541 5.19 ± 2.057 0.883
SD 26.05 ± 7.669 25.02 ± 6.86 0.227
SD1 3.98 ± 2.43 3.95 ± 2.191 0.917
SD2 5.42 ± 2.213 5.04 ± 1.70 0.099
SD3 2.81 ± 1.66 3.21 ± 1.436 0.144
SD4 5.2 ± 2.75 5.6 ± 2.243 0.315
SD5 8.94 ± 2.62 7.23 ± 2.291 < 0.001
C 26 ± 6.684 25.46 ± 6.459 0.373
C1 5.54 ± 1.793 5.49 ± 1.872 0.800
C2 3.8 ± 1.471 4.11 ± 1.472 0.401
C3 4.32 ± 1.592 4.44 ± 1.376 0.738
C4 6.51 ± 1.892 6.07 ± 2.034 0.170
C5 5.74 ± 1.729 5.28 ± 1.677 0.067
ST 18.2 ± 4.64 19.32 ± 4.958 0.176
ST1 5.68 ± 2.196 6.09 ± 2.081 0.350
ST2 5.10 ± 1.74 5.11 ± 2.102 0.701
ST3 7.43 ± 1.941 8.12 ± 2.376 0.410
TCI: Character and Temperament Inventory; NS: novelty seeking; HA: harm avoidance; RD: reward dependence; P: persistence; SD: self-directedness; C: cooperativeness; ST: self-transcendence.
Values are presented as mean ± standard deviation.
p < 0.05 is significant; NS: non significant.
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When the TCI scores were assessed in terms of the types of 
SNAP-25 gene polymorphism, no statistically significant relationship 
between TT, TG, GG genotypes for the MnlI gen and TCI scales 
was detected (p > 0.05). However, NS, NS4 score was found lower 
in the patients with TC genotype for DdeI gene (p < 0.05, Table 3), 
and HA, HA1, HA2 and C5 scores were found higher (p < 0.05). 
No statistically significant difference was found between TCI scores 
of the patients with and without C allele, although we assume the 
difference to be clinically significant. We found that NS and ST3 were 
significantly low, whereas; HA, HA1, HA2 and C5 were significantly 
high (p < 0.05), (Table 3). 
Discussion
The etiology of FMS is still unknown, but it seems to be multifactorial. 
FMS is classified as a functional somatic syndrome. Co-diagnosis 
of psychiatric disorders in FMS is common. In previous studies; 
depression, somatization disorder, bipolar disorder, anxiety and 
obsessive compulsive disorder have been found to be the most 
common coexisting disorders with FMS2,3. Cloninger et al. have 
found in their study that patients with chronic pains have higher HA, 
lower C and lower SD scores compared to healthy controls group13. 
It is assumed that personality also plays an important role in the 
etiology of psychosomatic illnesses. It is stated that there are specific 
personality traits for each psychosomatic illness14. 
Temperament is a tendency to react automatically against 
emotional stimulations in a naturally structurally certain way. 
Character is, on the other hand, relatively unchanging objectively 
observable behaviors, and subjectively stated internal experiences. 
Cloninger developed a dimensional psychobiological model of 
personality that accounted for both normal and abnormal variations 
of two major components of personality13. Cloninger’s personality 
model includes four temperaments (NS, HA, RD and persistence), 
and three character dimensions (SD, C and ST). There is limited 
research on character and temperament of FMS patients. The 
common finding of these studies is high scores of HA4,15-17. We also 
found higher HA in FMS patients compared to the healthy controls 
group in our study. It has been shown in studies that high HA is 
associated with severity somatization18. 
The findings we obtained from our study show that there are 
some differences in the personality traits and sub-dimensions of FMS 
patients compared to controls. Our study has found increased HA and 
decreased NS in FMS patients. There is limited research on character 
and temperament of FMS patients. However, only two of these 
studies used the TCI developed by Cloninger. The common finding 
of these studies is high scores of HA. These two studies conducted 
with TCI have reported high scores of HA and low scores of SD in 
FMS patients16,17. Conrad et al.19 found high HA and low SD scores 
in patients with chronic pains. Patients diagnosed with depression 
were also included in these studies, and a positive correlation has been 
Table 3. TCI scores of Patients Group and Control Group based on genotypes and alleles 
TCI Parameter TC Genotype (+) patients n = 47 TC Genotype (–) patients n = 38 p C allele (+) patients C allele (–) patients p
NS 14.84 ± 4.066 16.61 ± 4.753 0.042 14.72 ± 3.99 16.85 ± 4.78 0.025
NS1 5.41 ± 1.81 5.47 ± 2.58 0.898 5.44 ± 1.78 5.44 ± 2.64 0.992
NS2 3.81 ± 1.898 6.19 ± 10.436 0.176 3.77 ± 1.87 4.62 ± 1.97 0.062
NS3 3.3 ± 1.525 3.53 ± 1.52 0.520 3.18 ± 1.57 3.68 ± 1.43 0.162
NS4 2.27 ± 1.217 2.97 ± 1.5 0.031 2.28 ± 1.19 3.00 ± 1.53 0.035
HA 22.11 ± 6.244 18.64 ± 7.68 0.038 21.77 ± 6.48 18.82 ± 7.65 0.040
HA1 7.08 ± 1.6 6.19 ± 1.939 0.037 7.05 ± 1.66 6.18 ± 1.89 0.048
HA2 4.89 ± 1.449 3.5 ± 1.905 0.001 4.79 ± 1.47 3.53 ± 1.95 0.003
HA3 4.49 ± 2.388 3.19 ± 2.776 0.056 4.38 ± 2.43 3.24 ± 2.78 0.111
HA4 5.46 ± 2.317 5.56 ± 2.223 0.857 5.36 ± 2.36 5.68 ± 2.14 0.521
RD 12.95 ± 2.613 13.36 ± 3.339 0.555 12.85 ± 2.62 13.50 ± 3.35 0.362
RD1 7.3 ± 1.45 7.44 ± 1.681 0.690 7.23 ± 1.45 7.53 ± 1.67 0.404
RD3 3.57 ± 1.345 3.83 ± 1.444 0.418 3.54 ± 1.31 3.88 ± 1.47 0.386
RD4 2.08 ± 1.09 1.81 ± 1.238 0.316 2.08 ± 1.08 1.79 ± 1.25 0.214
P 5.54 ± 1.574 5.19 ± 1.489 0.338 5.56 ± 1.55 5.15 ± 1.50 0.133
SD 25.43 ± 6.743 25.5 ± 8.484 0.970 25.87 ± 6.85 25.00 ± 8.45 0.628
SD1 3.81 ± 2.158 4 ± 2.64 0.738 3.85 ± 2.13 3.97 ± 2.69 0.858
SD2 5.22 ± 2.275 5.56 ± 2.298 0.528 5.31 ± 2.26 5.47 ± 2.32 0.542
SD3 2.57 ± 1.537 2.83 ± 1.92 0.515 2.69 ± 1.59 2.71 ± 1.89 0.826
SD4 5.05 ± 2.677 4.86 ± 2.779 0.763 5.18 ± 2.66 4.71 ± 2.78 0.332
SD5 8.78 ± 1.315 8.94 ± 3.641 0.802 8.85 ± 1.30 8.29 ± 1.60 0.110
C 26.54 ± 6.09 25.39 ± 7.762 0.483 26.64 ± 5.98 25.21 ± 7.93 0.314
C1 5.54 ± 1.865 5.56 ± 1.843 0.973 5.56 ± 1.81 5.53 ± 1.89 0.864
C2 3.84 ± 1.385 3.86 ± 1.676 0.949 3.87 ± 1.39 3.82 ± 1.67 0.669
C3 4.14 ± 1.601 4.39 ± 1.695 0.513 4.13 ± 1.62 4.41 ± 1.67 0.812
C4 6.73 ± 2.023 6.39 ± 1.917 0.463 6.74 ± 1.98 6.35 ± 1.95 0.301
C5 6.05 ± 1.508 5.22 ± 1.987 0.047 6.10 ± 1.48 5.12 ± 1.99 0.025
ST 18.41 ± 4.862 18.67 ± 4.641 0.815 18.31 ± 4.78 18.79 ± 4.70 0.739
ST1 6 ± 2.273 5.64 ± 2.27 0.499 5.90 ± 2.26 5.74 ± 2.28 0.750
ST2 5.3 ± 1.762 5.17 ± 1.699 0.748 5.33 ± 1.78 5.12 ± 1.66 0.593
ST3 7.05 ± 1.747 7.92 ± 2.089 0.059 7.03 ± 1.73 8.00 ± 2.08 0.029
TCI: Character and Temperament Inventory; NS: novelty seeking; HA: harm avoidance; RD: reward dependence; P: persistence; SD: self-directedness; C: cooperativeness; ST: self-transcendence.
Values are presented as mean ± standard deviation.
p < 0.05 is significant; NS: non significant.
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found between low SD scores and depression scores16,17. It has been 
reported that there is an increase in HA scores and decrease in SD 
scores in emotional pathologies associated with depressive state20,21. 
Considering the likelihood of depression, we screened our patients 
with BDI and did not include the patients whom we found to have 
BDI scores higher than 17 in the study. Thus, we minimized the effect 
of depression on character and temperament. Therefore, SD score in 
FMS patients may have found to be normal, unlike in other studies. 
Patients with high HA behavior are defined as careful, 
meticulous, passive, fearful and insecure. Similar findings have been 
found in all these studies including our study, suggesting that these 
personality traits cause more susceptibility to developing mood and 
pain disorders. 
One of the hypotheses emphasized with respect to FMS 
etiopathogenesis is the serotonin (5-hydroxytryptamine) hypothesis22. 
Serotonin is found both in peripheral and in central serotonergic 
neurons. As known, serotonin and dopamine are the neurotransmitters, 
the roles of which have been widely discussed in the development of 
pain and etiology of depression and anxiety disorders. Serum levels 
of tryptophan, which is the precursor of serotonin, have been found 
to be low in patients with FMS23. In another study, decrease has been 
detected in 5-hydroxyindoleacetic acid levels, which is the serotonin 
metabolite, in cerebrospinal fluid of FMS patients24. 
SNARE proteins are proteins that have basic role in fusion 
between eukaryotic cells and organelles, and between organelles and 
plasma membrane7. SNAP-25 is a SNARE protein found in plasma 
membrane. These proteins play a very important role in formation of 
protein receptor complex which are responsible for the transmission 
of neurotransmitters between nerve cells. Neurotransmitters are 
found in synaptic vesicles and released at the synapse by way of 
calcium-dependent exocytose8. For this reason, SNAP-25 is important 
in the release of neurotransmitters such as serotonin and dopamine. 
Changes in the SNAP-25 functions may cause changes in the levels 
of serotonin and other neurotransmitters. Cloninger’s personality 
model makes it possible to correlate behavior appearances with 
neurotransmitters. In a study carried out by Peirson and Heuchert25, 
it was reported that HA tendency is linked to serotonin activation, 
and there is a negative correlation between seratonergic activation 
and HA tendency of the individuals. Individuals with high HA 
respond to stressful events with high levels of depressive signs. These 
individuals expect danger even when there is no danger13,26. This 
expectation leads to an inappropriate adaptation. Such individuals 
may have the tendency to wait for the pain to begin. No common 
personality profile has been established for psychosomatic illnesses. 
However, the common result is that the HA scores are high. Cloninger 
described that people with chronic anxiety difficultly calm down, get 
tired easily, and display specific signs based on specific anticipatory 
anxiety27. The high scores of HA, which we found in FMS patients, 
suggest that these patients may have a temperament with a tendency 
to develop pain symptoms as a response to stress. 
In a study of Balkarli et al.11, it was found that SNAP-25 gene 
polymorphism was more frequently detected in FMS. Depression 
and pain score was higher in patients with DdeI T/C genotype. In 
our study, we also found lower NS, lower NS4, higher HA, high 
HA1, high HA2, and high C5 in the patients with this genotype. We 
compared the TCI scores of patients with and without C allele, and 
we found difference in their TCI parameters (p < 0.005, Table 3). 
There is limited research on character and temperament of 
FMS patients15-17. Different inventories have been used in these 
studies. Personality models other than TCI have not taken into 
account the underlying social and biological identifiers, have failed 
in distinguishing types of memory. Cloninger’s psychobiological 
personality model (TCI) evaluates the responses of a person 
to novelty, danger and various types of reward with four basic 
personality dimensions. This way, it has been determined that basic 
emotions mediate perceptive information processes, and form early 
learning patterns such as unconscious responses to conditioned 
stimuli, and inherited tendencies of information processed by 
memory systems have been reflected13. Using the TCI to evaluate 
character and temperament in our study is supremacy of our 
study. Furthermore, most of these patients are also diagnosed with 
depression. Yet, higher HA, lower SD and lower persistence have been 
found in subjects with depression compared to healthy individuals. 
It has been reported that these personality traits may also be related 
to the severity of depressive symptomatology28-30. For this reason, we 
did not include patients with depression into our study. Therefore, 
we minimized the contribution of depression to personality traits. 
This is the supremacy of our study. 
Our study had various restrictions. First of all, the number of 
patients was limited, and we tried to explain pathology with only 
one gene. Serotonin and dopamine levels were not measured. The 
use of BDI instead of Structured clinical interview for DMS-IV 
diagnosis for the diagnosis of depression was another limitation. 
The fact that there was no psychiatric evaluation or screening test 
for other common diseases (such as bipolar disorder) was another 
shortcoming of this study. Although it was stated that patients with 
higher educational background were included in order to fill these 
form more accurately, level of education may an effect on severity 
of disease symptoms and temperament. 
In conclusion, SNAP-25 might be an etiological factor in FMS 
pathogenesis and might affect personality traits of FMS patients by 
mediating neurotransmitter release. The findings of our study may 
be considered as preliminary data, and further studies are required to 
be conducted. We think that studies with larger patient populations, 
in which serotonin and serotonin receptors will also be evaluated, 
will be beneficial for enlightening of the subject matter. 
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